Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

1.50
Delayed Data
As of Mar 29
 -0.08 / -5.06%
Today’s Change
0.86
Today|||52-Week Range
2.22
+71.43%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close1.58
Today’s open1.58
Day’s range1.44 - 1.58
Volume1,041,493
Average volume (3 months)649,804
Market cap$88.2M
Dividend yield--
Data as of 4:02pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)+9.09%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.90

Competitors

 Today’s
change
Today’s
% change
EPIXESSA Pharma Inc+0.01+0.47%
VCELVericel Corp0.000.00%
NAVBNavidea Biopharmaceu...+0.02+3.38%
SBPHSpring Bank Pharmace...-0.03-0.33%
Data as of 4:02pm ET, 03/29/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$24.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Kaushik J. Dave
Senior Director-Finance &
Corporate Development
Steve Oloughlin
Corporate headquarters
New York, New York

Forecasts


Search for Jobs